Early Weight Gain Related to Later Weight Gain in Adolescents on Depot Medroxyprogesterone Acetate
- 1 April 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 117 (4), 793-797
- https://doi.org/10.1097/aog.0b013e31820f387c
Abstract
OBJECTIVE: To examine whether early weight gain in adolescents on depot medroxyprogesterone acetate (DMPA) predicts continued excessive weight gain and identify risk factors of early weight gain. METHODS: Adolescents (n=97) initiating DMPA were eligible to participate. Height and weight were assessed at baseline and at 6, 12, and 18 months. Early weight gain was defined as more than a 5% weight gain after 6 months of DMPA use. Mean body mass index (BMI) at 6-month intervals was estimated based on early weight–gain status (5% or less gain compared with greater than 5% gain). Analysis of variance modeling was used to compare group BMI at each time point. Repeated-measures analysis of covariance modeling was used to explore the association between early weight gain and percentage change in BMI at 12 and 18 months of DMPA use. RESULTS: Twenty patients (21%) had early weight gain. Mean BMI for the 5% or less group and greater than 5% group was 23.4 and 24.5 (P=.31), 23.3 and 26.6 (P=.009), 24.2 and 28.7 (P=.007), and 25.7 and 32.1 (P=.01) at 0, 6, 12, and 18 months, respectively. Early weight gain was significantly associated with percentage change in BMI at 12 and 18 months (P<.001). No risk factors for early weight gain were identified. CONCLUSION: Adolescents who experience more than 5% weight gain after 6 months of DMPA use are at risk for continued excessive weight gain. Weight gain after 6 months on DMPA can be used to identify adolescents at risk for continued weight gain, and appropriate counseling can be done at this time point. LEVEL OF EVIDENCE: IIKeywords
This publication has 14 references indexed in Scilit:
- Early Weight Gain Predicting Later Weight Gain Among Depot Medroxyprogesterone Acetate UsersObstetrics & Gynecology, 2009
- Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective studyFertility and Sterility, 2008
- Weight Gain in Obese and Nonobese Adolescent Girls Initiating Depot Medroxyprogesterone, Oral Contraceptive Pills, or No Hormonal Contraceptive MethodArchives of Pediatrics & Adolescent Medicine, 2006
- Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girlsJournal of Adolescent Health, 2004
- Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA)Journal of Pediatric and Adolescent Gynecology, 2004
- Merits of DMPA relative to other reversible contraceptive methods.2002
- Overweight Teens at Increased Risk for Weight Gain While Using Depot Medroxyprogesterone AcetateJournal of Pediatric and Adolescent Gynecology, 2002
- Depomedroxyprogesterone acetate use and weight gain among adolescentsJournal of Pediatric and Adolescent Gynecology, 2000
- Depot Medroxyprogesterone Acetate or Oral Contraception in Postpartum AdolescentsObstetrics & Gynecology, 1998
- A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptivesContraception, 1995